Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma.
暂无分享，去创建一个
M. Atkins | J. Sosman | J. Kirkwood | M. Regan | M. Ernstoff | W. Urba | J. Mier | J. Gollob | J. Dutcher | D. McDermott | Joseph I. Clark | M. Gordon | K. Margolin | T. Logan | L. Flaherty | John W. Smith | G. R. Weiss | C. Tretter